๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA ยท Real-Time Price ยท USD
0.3470
-0.0198 (-5.40%)
At close: Nov 19, 2026, 4:00 PM EST
0.3600
+0.0130 (3.75%)
After-hours: Nov 19, 2026, 6:41 PM EST

Neumora Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-186.94-236.16-263.46-188.19-122.87-80.32
Net Income
-190.43-236.93-243.79-235.93-130.9-237.31
Earnings Per Share
-1.06-1.45-1.53-3.63-4.81-10.84
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
85.65182.53307.58463.83395.4409.25
Total Debt
53.5755.011.855.238.442.05
Net Cash (Debt)
32.09127.52305.73458.6386.95407.2
Net Cash Growth
-78.81%-58.29%-33.34%18.52%-4.97%114.39%
Net Cash Per Share
0.180.781.927.0514.2218.60

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-167.33-206.44-182.94-163.28-114.9-75.42
Capital Expenditures
0.02--0.78-4.71-13.51-0.82
Free Cash Flow
-167.31-206.44-183.71-167.99-128.41-76.24
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.